Related Experiment Video
Updated: Sep 23, 2025

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
Bio-inspired microcapsule for targeted antithrombotic drug delivery
Wei Ye1, Nan Wang1, Kebang Hu2
1Jiangsu Provincial Key Lab for Interventional Medical Devices, Huaiyin Institute of Technology Huaian 223003 China panchangjiang@hyit.edu.cn.
Researchers developed novel microcapsules for targeted antithrombotic drug delivery. These platelet-inspired microcapsules efficiently deliver nattokinase, reducing thrombosis risk and minimizing side effects.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmacology
Background:
- Thrombosis and embolism are leading global causes of death and disability.
- Current treatments carry risks of thrombosis and hemorrhage.
- Need for effective and targeted antithrombotic drug delivery systems.
Purpose of the Study:
- To develop a facile and versatile method for fabricating microcapsules for targeted antithrombotic drug delivery.
- To load and evaluate the release of nattokinase from these microcapsules.
- To assess the antithrombotic efficacy of the nattokinase-loaded microcapsules.
Main Methods:
- Fabrication of microcapsules via dopamine polymerization on polystyrene microspheres.
- Immobilization of fibrinogen and core removal to create poly(dopamine) microcapsules.
- Loading of nattokinase via diffusion and assessment of release kinetics at 37°C.
Main Results:
- Microcapsules achieved a nattokinase loading of approximately 0.05 mg g⁻¹ with nearly 75% efficiency.
- Nattokinase exhibited gradual release at 37°C.
- Demonstrated high efficiency in targeting activated platelets, dissolving fibrin clots, and prolonging blood clotting time.
Conclusions:
- Developed platelet-inspired microcapsules for targeted antithrombotic therapy with a gradual release mechanism.
- This strategy offers potential for reduced dosage, minimized side effects, and maximized efficacy.
- Provides a promising new approach for treating vascular disruption-related diseases.
More Related Videos
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

